Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Moving to NASDAQ once FDA designation is granted

<< Previous

Bullboard Posts

Next >>

Comment by Impalamanon Feb 01, 2023 9:48am

235 Views

Post# 35259151

RE:RE:RE:RE:RE:Moving to NASDAQ once FDA designation is granted

Longholder---I'm with you---I do hope they halt the stock---when the BTD news comes out----A halt will prevent a huge gap up---we do Not need another gap----I'm sure daytraders and shorts would love a big gap up---so they can pull the share price down again---Here's hoping for a HALT'

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario